Combined use of presepsin and (1,3)-ß-D-glucan as biomarkers for diagnosing Candida sepsis and monitoring the effectiveness of treatment in critically ill patients

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F22%3AE0109532" target="_blank" >RIV/00843989:_____/22:E0109532 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.mdpi.com/2309-608X/8/3/308" target="_blank" >https://www.mdpi.com/2309-608X/8/3/308</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3390/jof8030308" target="_blank" >10.3390/jof8030308</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Combined use of presepsin and (1,3)-ß-D-glucan as biomarkers for diagnosing Candida sepsis and monitoring the effectiveness of treatment in critically ill patients

Popis výsledku v původním jazyce

New biomarker panel was developed and validated on 165 critically ill adult patients to enable a more accurate invasive candidiasis (IC) diagnosis. Serum levels of the panfungal biomarker (1,3)-ß-D-glucan (BDG) and the inflammatory biomarkers C-reactive protein, presepsin (PSEP), and procalcitonin (PCT) were correlated with culture-confirmed candidemia or bacteremia in 58 and 107 patients, respectively. The diagnostic utility was evaluated in sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). BDG was the best marker for IC, achieving 96.6% sensitivity, 97.2% specificity, 94.9% PPV, and 98.1% NPV at a cut-off of 200 pg/mL (p&amp;amp;nbsp;? 0.001). PSEP exhibited 100% sensitivity and 100% NPV at a cut-off of 700 pg/mL but had a lower PPV (36.5%) and low specificity (5.6%). Combined use of PSEP and BDG, thus, seems to be the most powerful laboratory approach for diagnosing IC. Furthermore, PSEP was more accurate for 28-day mortality prediction the area under the receiver operating characteristic curve (AUC = 0.74) than PCT (AUC = 0.31; PCT cut-off = 0.5 ng/mL). Finally, serum PSEP levels decreased significantly after only 14 days of echinocandin therapy (p = 0.0012). The probability of IC is almost 100% in critically ill adults with serum BDG and PSEP concentrations &amp;gt; 200 pg/mL and &amp;gt;700 pg/mL, respectively, defining a borderline between non-invasive superficial Candida colonization and IC.

Název v anglickém jazyce

Combined use of presepsin and (1,3)-ß-D-glucan as biomarkers for diagnosing Candida sepsis and monitoring the effectiveness of treatment in critically ill patients

Popis výsledku anglicky

New biomarker panel was developed and validated on 165 critically ill adult patients to enable a more accurate invasive candidiasis (IC) diagnosis. Serum levels of the panfungal biomarker (1,3)-ß-D-glucan (BDG) and the inflammatory biomarkers C-reactive protein, presepsin (PSEP), and procalcitonin (PCT) were correlated with culture-confirmed candidemia or bacteremia in 58 and 107 patients, respectively. The diagnostic utility was evaluated in sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). BDG was the best marker for IC, achieving 96.6% sensitivity, 97.2% specificity, 94.9% PPV, and 98.1% NPV at a cut-off of 200 pg/mL (p&amp;amp;nbsp;? 0.001). PSEP exhibited 100% sensitivity and 100% NPV at a cut-off of 700 pg/mL but had a lower PPV (36.5%) and low specificity (5.6%). Combined use of PSEP and BDG, thus, seems to be the most powerful laboratory approach for diagnosing IC. Furthermore, PSEP was more accurate for 28-day mortality prediction the area under the receiver operating characteristic curve (AUC = 0.74) than PCT (AUC = 0.31; PCT cut-off = 0.5 ng/mL). Finally, serum PSEP levels decreased significantly after only 14 days of echinocandin therapy (p = 0.0012). The probability of IC is almost 100% in critically ill adults with serum BDG and PSEP concentrations &amp;gt; 200 pg/mL and &amp;gt;700 pg/mL, respectively, defining a borderline between non-invasive superficial Candida colonization and IC.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30221 - Critical care medicine and Emergency medicine

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of fungi

ISSN

2309-608X

e-ISSN

2309-608X

Svazek periodika

8

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

CH - Švýcarská konfederace

Počet stran výsledku

15

Strana od-do

1-15

Kód UT WoS článku

000776326700001

EID výsledku v databázi Scopus

2-s2.0-85127616615